Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MRNA - Moderna's COVID/flu combo vaccine succeeds in late-stage trial

MRNA - Moderna's COVID/flu combo vaccine succeeds in late-stage trial

Moderna Inc.

2024-06-10 08:10:22 ET

Moderna ( NASDAQ: MRNA ) said Monday that its investigational combination vaccine to protect against both COVID-19 and influenza elicited higher immune responses in adults 50 years and older compared to licensed comparator vaccines used in a late-stage trial....

For further details see:

Moderna’s COVID/flu combo vaccine succeeds in late-stage trial
Stock Information
Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com
Menu
MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...